JMVSX
Price
$35.26
Change
-$0.05 (-0.14%)
Updated
Jul 31 closing price
Net Assets
11.16B
JVMIX
Price
$31.39
Change
+$0.02 (+0.06%)
Updated
Jul 31 closing price
Net Assets
23.61B
Interact to see
Advertisement

JMVSX vs JVMIX

JMVSX vs JVMIX Comparison Chart in %
View a ticker or compare two or three
VS
JMVSX vs. JVMIX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVSX is a Buy and JVMIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JVMIX has more cash in the bank: 23.6B vs. JMVSX (11.2B). JMVSX pays higher dividends than JVMIX: JMVSX (0.77) vs JVMIX (0.66). JMVSX was incepted earlier than JVMIX: JMVSX (25 years) vs JVMIX (29 years). JMVSX (0.95) is less costly to investors than JVMIX (0.86). JVMIX is a more actively managed with annual turnover of: 48.00 vs. JMVSX (39.00). JVMIX has a lower initial minimum investment than JMVSX: JVMIX (250000) vs JMVSX (1000000). JVMIX annual gain was more profitable for investors over the last year : 8.75 vs. JMVSX (-2.75). JVMIX return over 5 years is better than : 15.79 vs. JMVSX (-17.66).
JMVSXJVMIXJMVSX / JVMIX
Total Expense Ratio0.840.8599%
Annual Report Gross Expense Ratio0.950.86110%
Fund Existence25 years29 years-
Gain YTD13.44914.27094%
Front LoadN/AN/A-
Min. Initial Investment1000000250000400%
Min. Initial Investment IRAN/AN/A-
Net Assets11.2B23.6B47%
Annual Yield % from dividends0.770.66116%
Returns for 1 year-2.758.75-31%
Returns for 3 years1.2218.936%
Returns for 5 years-17.6615.79-112%
Returns for 10 years5.9462.5110%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJGRX45.870.53
+1.17%
PGIM Jennison Growth R
GPEIX11.670.13
+1.13%
Grandeur Peak Emerg Mkts Opps Instl
NMUEX12.520.11
+0.89%
Neuberger Multi-Cap Opportunities E
SLADX45.450.38
+0.84%
Selected American Shares D
HGHTX50.23-0.41
-0.81%
Hartford Healthcare R5